in Resignations

Daiichi Sankyo Company CEO & President US Division Glenn Gormley Resigned

0 Comments

Chutes & Ladders-Doubling down on R&D, Daiichi makes changes to U.S. research unit

Daiichi Sankyo makes changes to its U.S. research unit; Immunomedics’ CEO quits; and Parexel nabs another key FDA oncology staffer. Those moves plus more hirings, firings and retirings throughout the industry.

Name: Glenn Gormley

Continent: Asia

Country: Japan

Company: Daiichi Sankyo Company

Position: CEO & President US Division

Reason: Resigned

Replaced By: Junichi Koga

Announcement Date: February 28, 2019, 11:00pm

Resignation Date: February 28, 2019, 11:00pm

Source 1: https://www.fiercebiotech.com/biotech/chutes-ladders-doubling-down-r-d-daiichi-makes-changes-to-u-s-research-unit

Add your submission

Image Video Audio Text Embed

This field is required
Delete

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required Learn more

This field is required
Delete

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required Learn more

This field is required
Delete

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required Learn more

This field is required Learn more

This field is required
Delete

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

This field is required Learn more

Report

AsiaCEO & President US DivisionDaiichi Sankyo CompanyGlenn GormleyJapanResigned

What do you think?

0 points

Leave a Reply